Quanterix Corp. Faces Delisting Notice

TL;DR

Quanterix got a notice about potentially getting delisted. Big trouble.

AI Summary

Quanterix Corporation filed an 8-K on November 21, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits.

Why It Matters

This filing indicates potential issues with Quanterix's stock listing, which could impact its market accessibility and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.

Key Players & Entities

• Quanterix Corporation (company) — Registrant
• November 21, 2024 (date) — Date of earliest event reported
• 001-38319 (company) — Commission File Number
• 900 Middlesex Turnpike (location) — Principal executive offices address
• Billerica, MA (location) — Principal executive offices city and state

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share QTRX The Nasdaq Glo

Filing Documents

• qtrx-20241121.htm (8-K) — 28KB
• qtrx-20241122xex991.htm (EX-99.1) — 8KB
• 0001503274-24-000020.txt ( ) — 162KB
• qtrx-20241121.xsd (EX-101.SCH) — 2KB
• qtrx-20241121_lab.xml (EX-101.LAB) — 21KB
• qtrx-20241121_pre.xml (EX-101.PRE) — 12KB
• qtrx-20241121_htm.xml (XML) — 3KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 21, 2024, Quanterix Corporation (the "Company") received a notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC. The Notice states that the Company has 60 calendar days from the date of the Notice, or until January 20, 2025, to submit a plan to regain compliance with the Rule. If Nasdaq accepts the Company's plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the prescribed due date of the Form 10-Q, or until May 13, 2025, to file the Form 10-Q to regain compliance with the Rule. The Notice has no immediate effect on the listing of the Company's securities on Nasdaq. As previously reported, the delay in filing the Form 10-Q is due to the need to restate the Company's audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024 and June 30, 2024. The Company currently intends to file the Form 10-Q with the SEC, or, if it is unable to do so, submit a plan to regain compliance to Nasdaq, on or before the January 20, 2025 deadline.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On November 22, 2024, the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that the Company had received the Notice. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Securities Act, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company's expectations with respect to the timing of the completion of the restatement and filing of the required filings. Statements using words such as "expect", "anticipate", "believe", "may", "will" and similar terms are also forward-looking statements. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risk that the Company may have underestimated the scope and impact of the restatement and the risk that the restated financial statements may take longer to complete than expected, as well as the important factors discussed under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as updated by its subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Except as required by law, the Company undertakes no obligations to make any revisions to the forward-looking statements contained in this Current Report or to update them to reflect events or circumstances occurring after the date of this Current Report, whether as a result of new information, future developments or otherwise.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated November 22, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. QUANTERIX CORPORATION By: /s/ Vandana Sriram Vandana Sriram Chief Financial Officer Date: Novem ber 22, 2024

View Full Filing

View this 8-K filing on SEC EDGAR